Aninternationalteamofresearchershasdevelopedanewdiagnosticandprognosismethodforearlydetectionofhepatocellularcarcinoma(HCC),basedonasimplebloodsamplecontainingc
The Chinese University of Hong Kong made public a set of scores on June 13 to predict risks of liver cancer in chronic hepatitis B patients who are receiving antiviral therapy.